An interactive distance learning event discussing 3 case studies in the areas of Choroidal Osteoma, RD from Stickler Syndrome, and Dislocated IOL.
Retina Rounds - June 2022
Media formats available:
Details
Presenters
Learning Objectives
Upon completion of this activity, the participant should be able to:
Identify common presentation of choroidal osteoma and understand safe diagnostic and treatment options in pregnant females.
Identify when common symptoms of RD, such as floaters, may be the sign of an uncommon disease such as Stickler Syndrome.
Understand the procedure and potential outcomes of SCILS for dislocated IOL.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Franco M. Recchia, MD
Pediatric Retina
Surgery and Diseases of the Retina and Vitreous
Tennessee Retina
Nashville, TN
David A. Reichstein, MD
Ocular Oncology
Surgery and Diseases of the Retina and Vitreous
Tennessee Retina
Nashville, TN
Ankoor R. Shah, MD
Retina Consultants of Texas
Houston, TXDISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.The following faculty/staff members have the following financial relationships with ineligible companies.
Franco M. Recchia, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Genentech. Grant/Research Support: Apellis, Genentech, Ionis Pharmaceuticals, Kodiak Sciences, and RegenxBio. Speaker's Bureau: Genentech.
David A. Reichstein, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Aura Biosciences, Castle Biosciences, Genentech, and Regeneron Pharmaceuticals. Speaker's Bureau: Genentech. Grant/Research Support: Allergan, Aura Biosciences, Castle Biosciences, Genentech, and Regeneron.
Ankoor R. Shah, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb and RegenxBio.
The Evolve staff, RCA staff, planners and reviewers have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Retina Consultants of America.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!